Bio Solution Co.,Ltd. (KOSDAQ:086820)
South Korea · Delayed Price · Currency is KRW 8,950.00
-400.00 (-4.28%)
At close: Feb 27, 2026
Bio Solution Market Cap
Bio Solution has a market cap or net worth of 216.34 billion as of February 27, 2026. Its market cap has increased by 1.75% in one year.
Market Cap
216.34B
Enterprise Value
235.77B
Revenue
8.27B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,950.00
Market Cap Chart
Since August 20, 2018, Bio Solution's market cap has decreased from 218.31B to 216.34B, a decrease of -0.90%. That is a compound annual growth rate of -0.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 216.34B | 13.15% |
| Dec 30, 2025 | 191.20B | 10.84% |
| Dec 30, 2024 | 172.51B | 10.88% |
| Dec 28, 2023 | 155.58B | 82.92% |
| Dec 29, 2022 | 85.05B | -50.94% |
| Dec 30, 2021 | 173.35B | -26.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NIBEC | 352.91B |
| ABION | 288.32B |
| Genome & Company | 223.32B |
| ISU Abxis | 219.48B |
| Prestige Biologics | 217.32B |
| QuadMedicine | 207.14B |
| Kangstem Biotech | 204.10B |
| Ensol Biosciences | 197.23B |